Sino Biopharmaceutical (01028.HK) issued a total of 249 million purchase rights.

The Zhitong Finance APP news, Qianbaodu (01028.HK) announced that on May 22, 2026, the company granted a total of 249 million share options to several grantees under the stock purchase plan.